195 related articles for article (PubMed ID: 11832369)
1. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.
Johnson PM; Vogt SK; Burney MW; Muglia LJ
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E650-6. PubMed ID: 11832369
[TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
Oka T; Shearer T; Azuma M
Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
[TBL] [Abstract][Full Text] [Related]
3. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes.
Swiergiel AH; Dunn AJ
J Pharmacol Exp Ther; 2002 Sep; 302(3):1031-6. PubMed ID: 12183660
[TBL] [Abstract][Full Text] [Related]
6. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
Zhang YH; Lu J; Elmquist JK; Saper CB
J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury.
Song AM; Bhagat L; Singh VP; Van Acker GG; Steer ML; Saluja AK
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1166-74. PubMed ID: 12381531
[TBL] [Abstract][Full Text] [Related]
10. The role of cyclooxygenases in inflammation, cancer, and development.
Williams CS; Mann M; DuBois RN
Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
Gierse JK; Staten NR; Casperson GF; Koboldt CM; Trigg JS; Reitz BA; Pierce JL; Seibert K
Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
[TBL] [Abstract][Full Text] [Related]
13. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
Xu H; Izon DJ; Loftin C; Spain LM
Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice.
Sasaki T; Kitagawa K; Yamagata K; Takemiya T; Tanaka S; Omura-Matsuoka E; Sugiura S; Matsumoto M; Hori M
J Cereb Blood Flow Metab; 2004 Jan; 24(1):107-13. PubMed ID: 14688622
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test.
Padi SS; Kulkarni SK
Indian J Exp Biol; 2005 Jan; 43(1):53-60. PubMed ID: 15691066
[TBL] [Abstract][Full Text] [Related]
18. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
